P. Romanchuk

P. Romanchuk

Auto-generated profile, based on publicly available information

P. Romanchuk

Samara State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2020 in Bulletin of Science and Practice
Verified
Journal Article
Open access
PRP. Romanchuk
P. Romanchuk
The main modern tools and techniques of epigenetic, dietary and biomicrobiotic protection of healthy ageing have been studied. Artificial intelligence, brain-microbiota neural networks allow to control interaction of genetic and epigenetic programs of ageing and healthy longevity. The new managed healthy biomicrobiota and personalized functional and balanced nutrition of ‘brain and microbiota’ is a long-term medical program of the patient, which allows the combined application of nutritional epigenetics and pharmacepigenetics, and the main thing to carry out prevention of polypragmasia. Multimodal tools, biochyping, neural and brain chips, next-generation (new) sequencing technologies create biomarkers to manage the structure of healthy biomicrobiota and functional nutrition, depending on the targets achieved. A functional food product using biomarkers and artificial intelligence technologies is a target breeding ground for both the body in general and biomicrobiota in particular. Chronomedical technologies are mathematical models and artificial intelligence that predict human biological age using DNA methylation data, histone modifications, nucleosome remodeling, and microRNA, and are the most accurate biomarkers of the aging process. Epigenetic mechanisms (DNA methylation, histone modifications, ncRNAs) are interconnected and form an ‘epigenetic network’. Lifestyle factors and environmental exposures leave epigenetic marks on our DNA that impact gene expression; some have protective effects while others are harmful. Genetic and epigenetic factors that ensure longevity and super-longevity require a reasonable new human interaction with nature and society, and responsibility for future healthy generations.

15 January 2020 in Bulletin of Science and Practice
Verified
Journal Article
Open access
PRP. Romanchuk
P. Romanchuk
AVA. Volobuev
A. Volobuev
The human brain is the main tool and the most valuable resource on our planet. New epigenetics Homo sapiens and H. sapiens brain manage the interaction of genetic and epigenetic programs of aging and healthy longevity. Epigenetic clocks are mathematical models and artificial intelligence that predict the biological age of a person using DNA methylation data and are the most accurate biomarkers of the aging process. Genetic and epigenetic factors that limit a person’s life expectancy are relevant in biogerontological, biophysical and neurophysiological studies, especially from the point of view of the medical economy. Cerebrovascular aging can be considered from several points of view, including changes in vascular density (number of capillaries and arterioles), vascular plasticity (dynamic regulation of vascular density or structure) and vascular reactivity (adaptation of vessels to acute metabolic changes in tissues). The main control mechanisms in the cerebral circulation are unique in comparison with other vascular channels and include, but are not limited to such features as the blood-brain barrier, perivascular innervation, intracellular communication between neurons, perivascular glial cells and smooth muscle cells, high tissue metabolism, lack of anoxic tolerance and the presence of collateral arteries. Multidisciplinary and multimodal interaction in the triad brain-eyes-vessels makes it possible to identify early biomarkers of both general accelerated and pathological aging, and to diagnose neurodegeneration in a timely manner, and to carry out effective neurorehabilitation of cognitive impairment. Biochipping, neural and brain chips, the next (new) generation sequencing technology will allow the study of the expression of thousands of genes that will be used as biomarkers. Combined and hybrid methods of neuroimaging in collaboration with artificial intelligence technologies are modern tools for the diagnosis and prevention of cognitive impairment and healthy aging of the H. sapiens brain.

15 November 2019 in Bulletin of Science and Practice
Verified
Journal Article
Open access
NRNatalia Romanchuk
Natalia Romanchuk
PRP. Romanchuk
P. Romanchuk
Doctor and neurophysiologist: a modern solution to problems of rehabilitation ‘cognitive brain’ of Homo sapiens using on the one hand, tools and technologies of artificial intelligence, and with another — a multidisciplinary collaboration with clinical neurophysiologist ‘universal’ specialist in the field of neurology, psychiatry, psychotherapy, psychoanalysis and geriatrics. Modern artificial intelligence technologies are capable of many things, including predicting Alzheimer’s disease with the help of combined and hybrid neuroimaging, sequencing of a new generation, etc., in order to start timely and effective rehabilitation brain H. sapiens. The H. sapiens brain is the next frontier for health care. Through the fusion of combined and hybrid neuroimaging techniques with artificial intelligence technologies, it will be possible to understand and diagnose neurological disorders and find new methods of rehabilitation and medical and social support that will lead to improved mental health. To restore circadian neuroplasticity of the brain, a multimodal scheme is proposed: circadian glasses, functional nutrition and physical activity. A combined and hybrid cluster in the diagnosis, treatment, prevention and rehabilitation of cognitive disorders and cognitive disorders has been developed and implemented.

15 April 2019 in Bulletin of Science and Practice
Verified
Journal Article
Open access
AVA. Volobuev
A. Volobuev
PRP. Romanchuk
P. Romanchuk
Modern rational pharmacotherapy allows being provided with a balance of efficacy and safety in clinical geriatrics, which is especially important in patients with neurovascular degeneration, including in the presence of severe forms of vascular comorbidity, requiring multi–component therapy, under the condition of active multidisciplinary and interdepartmental impact. Dementia in its origin is mixed and it is extremely difficult to divide into parts its primary degenerative or vascular component. The differentiated approach is determined by the heterogeneity of the pathological process, which common is the relationship of cerebral vascular damages with the development of the brain symptoms damage. The problem of nosological independence of Alzheimer’s disease is the subject of discussion for patients of older age groups (especially in people 65 years and older). The genesis of mnestic–intellectual disorders is due not so much to primary–degenerative as vascular changes, especially at the level of the microcirculatory canal. The modern problem of neurodegeneration has a neurophysiological, biophysical, gerontological, geriatric and strategic practical orientation since the diagnosis of the cause of the disease determines the choice of adequate treatment. Due to a large number of pathogenetical mechanisms, there is no single and standardized method of treatment for vascular dementia and Alzheimer’s disease. In any case, prevention of the development and progression of vascular dementia and Alzheimer’s disease should take into account the etiological mechanisms of its occurrence, because it will vary in patients with failures of small vessels, occlusive damages of the main arteries of the head or an embolism of cardiogenic origin. In patients with failures of small vessels, the main direction of therapy should be the normalization of blood pressure, which leads to improved cognitive functions. At the same time, excessive lowering of blood pressure can provoke an increase in mnestic-intellectual disorders, possibly caused by a secondary decrease in cerebral blood flow due to a violation of autoregulation. Biophysics of blood circulation in Alzheimer’s disease is characterized by disorders of laminar blood flow and cerebral hypoperfusion. As a result, failure intracellular metabolism, there is a cascade of changes in neurons associated with the processes of excitotoxicity and oxidant stress, which in turn stimulates amyloidogenesis. Experimental and 25-year observations have shown that the long–existing state of hypoperfusion leads to hippocampal disorders. This process is accompanied by memory impairment, structural changes in the capillaries in the hippocampus, impaired glucose and protein metabolism, β–amyloid deposition, activation of glial tissue, the death of hippocampal neurons.

15 November 2019 in Bulletin of Science and Practice
Verified
Journal Article
Open access
SBS. Bulgakova
S. Bulgakova
PRP. Romanchuk
P. Romanchuk
NRNatalia Romanchuk
Natalia Romanchuk
VPV. Pyatin
V. Pyatin
DRD. Romanov
D. Romanov
AVA. Volobuev
A. Volobuev
Modern technologies and tools for the rehabilitation of patients with Alzheimer’s disease have many potential applications for the treatment of dementia from diagnosis and evaluation to medical care, medical, social and economic support: from healthy aging, to accelerated and pathological aging of Homo sapiens. Doctor and neuroscientist: a modern solution to problems of rehabilitation ‘cognitive brain’ of Homo sapiens using on the one hand, tools and technologies of artificial intelligence, and with another — a multidisciplinary collaboration with clinical neurophysiologist ‘universal’ specialist in the field of neurology, psychiatry, psychotherapy, psychoanalysis and geriatrics. Systems biology, Biophysics, physiology, neurophysiology and highlight the multidimensional and combinatorial profiles of genetic, biological, pathophysiological and clinical biomarkers that reflects the heterogeneity of neurodegeneration, by means of modern efficient analysis tools to register and create comprehensive maps of the brain and recording of dynamic models in different systems: from molecules to neurons to brain regions. Bioinformatics, neuroimaging and neurophysiology of systems are aimed at calculating neural network models of the relationship between structure and dynamic function in brain networks. Structural and functional markers of the brain establish a link between clinical phenotypes and molecular pathophysiological mechanisms. Phenotypic variability is now considered one of the biggest problems in gerontology and geriatrics. MRI imaging to detect subtle changes in brain tissue and structure, fMRI imaging to measure changes in brain activity, and EEG to measure electrical activity have given clinicians many new insights into what happens in the brain in healthy and pathological aging. The paradigm of system neurophysiology is aimed at studying the fundamental principles of functioning of integrated neural systems through the integration and analysis of neural information recorded in a multimodal way (for example, fMRI and EEG), through computational modeling and combining data mining methods. The ultimate goal of systemic neurophysiology is to find out how signals are represented in neocortical networks and what role many different neural components play. Modern artificial intelligence technologies are capable of many things, including predicting Alzheimer's disease with the help of combined and hybrid neuroimaging, sequencing of a new generation, etc., in order to start timely and effective rehabilitation brain Homo sapiens.

15 March 2020 in Bulletin of Science and Practice
Verified
Journal Article
Open access
SBS. Bulgakova
S. Bulgakova
PRP. Romanchuk
P. Romanchuk
ETE. Treneva
E. Treneva
The last four decades have been marked by a number of scientific discoveries. So, it became known that insulin, receptors for it are found in the structures of the brain. In addition, the role of this hormone in the activation of neuronal stem cells, growth, development of the neuronal network, synaptic transmission, cognitive functions and so on has become known. Signal dysfunction and insulin metabolism contribute to the development of a number of degenerative diseases of the brain. More and more evidence suggests a relationship between type 2 diabetes mellitus and Alzheimer’s disease, which share many common pathophysiological characteristics. This review of the literature is devoted to the analysis of clinical and experimental data linking insulin, insulin resistance with degenerative processes in the brain, and the evaluation of pharmacological strategies aimed at the correction of insulin signaling pathways in the central nervous system and cognitive functions. Artificial intelligence, brain–microbiota neural networks allow to control interaction of genetic and epigenetic programs of ageing and healthy longevity. The new managed healthy biomicrobiota and personalized functional and balanced nutrition of ‘brain and microbiota’ is a long-term medical program of the patient, which allows the combined application of nutritional epigenetics and pharmacepigenetics, and the main thing to carry out prevention of polypragmasia.